Vera Therapeutics, Inc.
VERA
$34.15
-$1.13-3.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.12% | -110.28% | -96.92% | -87.49% | -102.39% |
| Total Depreciation and Amortization | 89.40% | 192.18% | 345.71% | 618.52% | 686.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.90% | 210.88% | 138.38% | 137.36% | 124.50% |
| Change in Net Operating Assets | -112.37% | 915.86% | 764.36% | 806.47% | 196.08% |
| Cash from Operations | -82.79% | -88.85% | -79.02% | -74.31% | -73.59% |
| Capital Expenditure | 79.81% | 59.79% | 35.19% | -200.77% | -740.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.15% | 121.99% | 145.96% | 42.29% | 33.38% |
| Cash from Investing | 132.66% | 121.61% | 145.71% | 41.78% | 32.81% |
| Total Debt Issued | -100.00% | -- | -- | -5.67% | -5.67% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.20% | -12.36% | -52.47% | 17.21% | 17.38% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.01% | -0.31% | 45.39% | -39.18% | -39.18% |
| Cash from Financing | -15.95% | -6.14% | -49.08% | 14.08% | 14.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.02% | 522.84% | 458.03% | 16,595.68% | 373.01% |